Chong Kun Dang Reports 43.3 Billion KRW Operating Profit in Q2, Up 54.4% Year-on-Year
Jongkundang announced on the 28th that its sales for the third quarter of this year reached 391.841 billion KRW, a 7.4% increase compared to the same period last year. Operating profit during this period was 43.392 billion KRW, up 54.4%. Net profit was 41.831 billion KRW, a 70.9% increase. This was the result of increased sales of pharmaceuticals such as the diabetes treatment Jinuvia and the new drug for gastroesophageal reflux disease, K-CAB.
Hot Picks Today
As Samsung Falters, Chinese DRAM Surges: CXMT Returns to Profit in Just One Year
- "Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- Man in His 30s Dies After Assaulting Father and Falling from Yongin Apartment
- Samsung Union Member Sparks Controversy With Telegram Post: "Let's Push KOSPI Down to 5,000"
- "Why Make Things Like This?" Foreign Media Highlights Bizarre Phenomenon Spreading in Korea
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
